Physician Resource Center
Specialties
Featured Content View More
Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies
CAR T-cell therapies are the future of cancer treatment and Roswell Park Comprehensive Cancer Center is preparing to open a number of new trials based on research originating here and in partnership with the industry.
Experts from Roswell Park Comprehensive Cancer Center discuss genetic testing for mitigating and understanding the cancer risks of their patients.
Roswell Park Team Gets the Call: ‘You’ve Earned Magnet Recognition for Nursing Excellence’
Roswell Park is among only about 10 percent of U.S. hospitals that have ever achieved Magnet recognition.
Phase 3 clinical trial is underway, it will evaluate the potential of combining an investigational drug, the targeted therapy XL092 (brand name Zanzalintinib), with the FDA-approved immunotherapy nivolumab (brand name Opdivo).
Surgical Options for Treating Acromegaly
Acromegaly is a rare condition in which a tumor within the pituitary gland causes excessive release of growth hormones.
Roswell Park Accelerates CAR T-Cell Innovation with Upcoming Trials
Renier Brentjens, MD, PhD, has spent most of his career pioneering research into the development and use of CAR T-cell therapies in the hopes of finding innovative and effective treatments for cancer.
Featured CMEs
This site is intended for healthcare professionals
Roswell Park News
Monday, March 17, 2025 10:23 AM
Roswell Park’s Intensive Care Unit Earns National Recognition for Exceptional Patient Outcomes
Wednesday, February 26, 2025 3:10 PM
Fifth annual IceCycle to end cancer raises $735,000
Saturday, March 8, 2025 7:48 PM